14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.87 3.40 %
R2 4.80 1.98 %
R1 4.76 1.10 %
Current price: 4.71
Support S1 4.63 -1.74 %
S2 4.59 -2.61 %
S3 4.52 -4.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.29 12.31 %
R2 4.94 4.88 %
R1 4.88 3.61 %
Current price 4.71
Support S1 4.41 -6.37%
S2 4.30 -8.70%
S3 4.15 -11.89%

NVAX Predictions History

2 years ago
AlexVel predicted that NVAX for 2021-12-27 is going $174.31 (10.46%)

2 years ago
JS predicted that NVAX for 2021-12-27 is going $174.06 (10.30%)

2 years ago
do.roerig.281439 predicted that NVAX for 2021-12-27 is going

Rank:

2 years ago
davedammitt.248165 predicted that NVAX for 2021-08-10 is going

Rank:

2 years ago
RamboRex3000 predicted that NVAX for 2021-08-10 is going $218.56 (-5.06%)

2 years ago
JS predicted that NVAX for 2021-08-10 is going $221.18 (-3.92%)

2 years ago
Chris Creager predicted that NVAX for 2021-08-10 is going $215.41 (-6.43%)

Rank:

2 years ago
puskelya.234599 predicted that NVAX for 2021-07-29 is going

Rank:

2 years ago
JS predicted that NVAX for 2021-05-12 is going $133.01 (4.06%)

2 years ago
drgrigorescu.238094 predicted that NVAX for 2021-05-12 is going

Rank:
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT